Investor Perspectives – How to Solve the Biotech/Life Sciences Problem: Growth in the Biotech/Life Sciences Segment

This is Investor Perspectives. I’m the host of Investor Connect, Hall T Martin, where we connect startups and investors for funding.

In our new Investor Perspectives series entitled “How to Solve the Biotech/Life Sciences Problem”, you’ll hear about growth in the biotech/life sciences segment.

As the COVID pandemic passes, we emerge into a new world. The biotech space is now undergoing tremendous change as we shift back to a normal way of life. The process for designing and approving vaccines demonstrated a new protocol. Biotech now moves into a new era. We have investors and startup founders describe the changes coming up.

Our guests are:

Yaniv Sneor, Co-founder, Mid Atlantic Bio Angels, 01:18
Carter Williams, CEO and Managing Partner, iSelect Fund, 05:05
Maximilian Bade, Founding Partner, Nucleus Capital, 07:35
Ron Paliwoda, President, Paliwoda Group, 10:34
Orrin Ailloni-Charas, Managing Partner, Global Health Impact Fund, 16:36
Eyal Lifschitz, Co-Founder and Managing Partner, Peregrine Ventures, 20:31
Mark Groper, Chief Executive Officer, Orion Biotechnology, 29:20

I hope you enjoy this episode.
________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org       

Check out our other podcasts here: https://investorconnect.org/ 
For Investors check out: https://tencapital.group/investor-landing/  
For Startups check out: https://tencapital.group/company-landing/  
For eGuides check out: https://tencapital.group/education/  
For upcoming Events, check out https://tencapital.group/events/    

For Feedback please contact [e-mail] 

Music courtesy of Bensound.